Join the Influenza Prophylaxis group to help and get support from people like you.
Influenza Prophylaxis News (Page 2)
Related terms: Flu Prevention
What You Need to Know About FluMist, the Nasal Flu Vaccine
SATURDAY, Oct. 26, 2024 – Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know that it's the right choice for you and your...
This Season's Flu Vaccine Cuts Risk of Hospitalization by Almost 35%
THURSDAY, Oct. 3, 2024, HealthDay News – The Southern Hemisphere's flu season is winding down, and new data shows this year's flu shot was 34.5% effective in keeping folks there who got influenza...
FluMist Approved for Self-Administration in the US
20 September 2024 – FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49...
Most Americans Won't Get Vaccinated as Flu, COVID Season Looms: Survey
WEDNESDAY, Sept. 25, 2024 – Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, a new survey has found. Fewer than two in five U.S. adults (38%) say they will d...
FDA Approves First Flu Vaccine That Can Be Self-Administered at Home
FRIDAY, Sept. 20, 2024 – On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a "new option for receiving a safe and effective...
No Perinatal Risks Seen With Influenza Vaccination in Successive Pregnancies
FRIDAY, Sept. 20, 2024 – Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes, according to a study published online...
FDA Approves First Flu Vaccine You Give Yourself at Home, FluMist
FRIDAY, Sept. 20, 2024 – The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the...
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
THURSDAY, Sept. 12, 2024 – A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the p...
Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person
South San Francisco, CA – November 23, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ – The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6...
GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
Philadelphia, PA, January 11, 2018 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research e...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
GSK Receives FDA Approval for Expanded Indication for FluLaval Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
18 November 2016 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication ...
FDA Approves Flublok Quadrivalent Influenza Vaccine
MERIDEN, Conn., Oct. 11, 2016 /PRNewswire/ – Protein Sciences Corporation announced today that the FDA has approved its quadrivalent formulation of Flublok influenza vaccine. Flublok Quadrivalent...